RFP QuestBeta
ClosedStage · tender

CELL AND GENE THERAPY CATAPULT

Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses

Engineering & ArchitectureCPV 73300000
Value£180k
Deadline10 Nov 2022
Published10 Oct 2022
RegionNationwide
Timeline
Published 10 Oct 2022ClosedCloses 10 Nov 2022
Who to contact
procurement@ct.catapult.org.uk

The procurement contact named on the official notice.

Contract value in context
£180ktotal contract value
median £66k
this tender£0£561k

This is a large award for Research & Development — above three-quarters of comparable contracts. Based on 20,405 valued Research & Development tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).

Briefly, human cells will be subjected to AAV production in parallel with controls.

A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample).

The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B).

In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion.

Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded.

A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3".

Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs.

This will be to ensure robustness of the findings or to meet unforeseen project needs.

This will be based on satisfactory performance and continued need.

Key requirements

What the supplier must deliver

01

Cell Therapy Catapult Ltd is seeking through

Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV).

02

This will be to ensure robustness

This will be to ensure robustness of the findings or to meet unforeseen project needs.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at CELL AND GENE THERAPY CATAPULT, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
ocds-h6vhtk-037448
Stage
tender · Open
Source
Find a Tender
Buyer ref
028371-2022
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

Assembling the market network…

CELL AND GENE THERAPY CATAPULT’s tender network

Assembling the network…